# Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine in Indian Infants Previously Given a Dose of Hepatitis B Vaccine at Birth

> **NCT01948193** · PHASE3 · COMPLETED · sponsor: **Sanofi Pasteur, a Sanofi Company** · enrollment: 177 (actual)

## Conditions studied

- Diphtheria
- Tetanus
- Whooping Cough
- Hepatitis B
- Poliomyelitis
- Invasive Hib Infections

## Interventions

- **BIOLOGICAL:** Hexaxim™: DTaP-IPV-Hep B-PRP~T combined vaccine

## Key facts

- **NCT ID:** NCT01948193
- **Lead sponsor:** Sanofi Pasteur, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2014-12
- **Final completion:** 2015-06
- **Target enrollment:** 177 (ACTUAL)
- **Last updated:** 2015-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01948193

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01948193, "Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine in Indian Infants Previously Given a Dose of Hepatitis B Vaccine at Birth". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01948193. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*